Devicemaker Conformis announced Feb. 11 a public offering of common stock.
The company will grant underwriters a 30-day option to purchase additional shares of common stock. All shares are being offered by Conformis.
The company said it will use any proceeds to fund research and development and sales and marketing costs, clinical studies, manufacturing development, potential acquisitions and repayment or refinance of debt.
Conformis has not priced the offering.